[1]
L. Wang, Z. Teng, and D. Cai, “Retraction: Monotherapy with meropenem versus combination therapy of ceftazidime plus amikacin for empirical treatment of cancer patients with Febrile Neutropenic (FN): systematic review and meta-analysis”, Eur J Oncol Env Hea, vol. 20, no. 1, pp. 5–16, Sep. 2015, Accessed: Feb. 23, 2025. [Online]. Available: https://mattioli1885journals.com/index.php/EJOEH/article/view/4122